EP0607275A4 - Treating ophthalmic fibrosis using interferon-alpha. - Google Patents

Treating ophthalmic fibrosis using interferon-alpha.

Info

Publication number
EP0607275A4
EP0607275A4 EP92921557A EP92921557A EP0607275A4 EP 0607275 A4 EP0607275 A4 EP 0607275A4 EP 92921557 A EP92921557 A EP 92921557A EP 92921557 A EP92921557 A EP 92921557A EP 0607275 A4 EP0607275 A4 EP 0607275A4
Authority
EP
European Patent Office
Prior art keywords
interferon
alpha
treating ophthalmic
ophthalmic fibrosis
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92921557A
Other languages
German (de)
French (fr)
Other versions
EP0607275A1 (en
Inventor
Mark Cedric Gillies
Nigel Morlet
Marc George Sarossy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0607275A1 publication Critical patent/EP0607275A1/en
Publication of EP0607275A4 publication Critical patent/EP0607275A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP92921557A 1991-10-11 1992-10-12 Treating ophthalmic fibrosis using interferon-alpha. Withdrawn EP0607275A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPK886591 1991-10-11
AU8865/91 1991-10-11
AU9080/91 1991-10-22
AUPK908091 1991-10-22
PCT/AU1992/000541 WO1993006856A1 (en) 1991-10-11 1992-10-12 Treating ophthalmic fibrosis using interferon-alpha

Publications (2)

Publication Number Publication Date
EP0607275A1 EP0607275A1 (en) 1994-07-27
EP0607275A4 true EP0607275A4 (en) 1995-02-22

Family

ID=25644122

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92921557A Withdrawn EP0607275A4 (en) 1991-10-11 1992-10-12 Treating ophthalmic fibrosis using interferon-alpha.

Country Status (4)

Country Link
EP (1) EP0607275A4 (en)
JP (1) JPH07501320A (en)
CA (1) CA2120950A1 (en)
WO (1) WO1993006856A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761229B1 (en) * 1995-03-17 2004-08-04 Toray Industries, Inc. Corneal vascularization inhibitor
CA2210622A1 (en) * 1995-11-17 1997-05-29 Toray Industries, Inc. An agent protecting endothelial cells
EP0878200B1 (en) * 1996-11-22 2003-05-21 Toray Industries, Inc. Therapeutic agent for ophthalmic diseases
WO1998029069A2 (en) * 1997-01-02 1998-07-09 Allergan Sales, Inc. Method for changing the refractive power of an eye
AR054513A1 (en) * 2005-06-24 2007-06-27 Ct Ingenieria Genetica Biotech USE OF INTERFERON ALFA FOR THE OBTAINING OF A COMPOSITE FOR THE TREATMENT OF OPTICAL NEUROMYELITIS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6391331A (en) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk Ophthalmic aqueous composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
DE3603444A1 (en) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA
DE3628468A1 (en) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K NEW APPLICATION FORM (ALPHA) INTERFERONE
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6391331A (en) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk Ophthalmic aqueous composition

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ANN. OTTALMOL. CLIN. OCUL., vol. 116, no. 1, 1990, pages 41 - 47 *
BIOLOGICAL ABSTRACTS, vol. 84, no. 10, 1987, Philadelphia, PA, US; abstract no. 104066, IHKI KOHTAROH ET AL: "Toxicity of intravitreal interferon in combination with acyclovir after lensectomy and vitrectomy" page AB-1123; *
BIOLOGICAL ABSTRACTS, vol. 90, no. 7, 1990, Philadelphia, PA, US; abstract no. 72950, C. D. INCORVAIA ET AL: "Alpha-interferon and acyclovir in the treatment of experimental herpetic keratitis" page AB-189; *
BIOLOGICAL ABSTRACTS, vol. 91, no. 11, 1991, Philadelphia, PA, US; abstract no. 116076, M. SALDUCCI ET AL: "Natural alpha interferon eye-drops for therapy of viral conjunctivitis and /or keratitis" page AB-208; *
BOLL. OCUL., vol. 69, no. 2, 1990, pages 217 - 226 *
FOLIA OPHTHALMOL. JPN, vol. 38, no. 2, 1987, pages 158 - 161 *
PATENT ABSTRACTS OF JAPAN vol. 12, no. 326 (C - 525)<3173> 5 September 1988 (1988-09-05) *
See also references of WO9306856A1 *

Also Published As

Publication number Publication date
CA2120950A1 (en) 1993-04-15
WO1993006856A1 (en) 1993-04-15
JPH07501320A (en) 1995-02-09
EP0607275A1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
ZA919797B (en) Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
HU9601504D0 (en) Infuser
GB9127150D0 (en) Novel treatment
EP0666752A4 (en) Therapeutic microemulsions.
ZA927562B (en) Medicament.
GB9203039D0 (en) Treatment
GB9320676D0 (en) Treatment fo wood
EP0607275A4 (en) Treating ophthalmic fibrosis using interferon-alpha.
GB9201920D0 (en) Novel treatment i
ZA931481B (en) Implants.
EP0586848A3 (en) Implant.
ZA942809B (en) Treatment
ZA929916B (en) Therapeutic agents.
PH31066A (en) Treatment composition.
EG19223A (en) Therapeutic agents.
CA68941S (en) Goggles
CA68940S (en) Goggles
CS193790A2 (en) N-nitrosodimethylamine and 1,3,5-trinitrosotriazine removal
GB9020697D0 (en) Treatment
GB9009388D0 (en) Treatment
GB9014981D0 (en) New treatment
GB2279548B (en) Crop treatment
GB9104175D0 (en) New treatment
GB9127464D0 (en) Flour treatment
GB9008233D0 (en) Wood treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940427

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

17Q First examination report despatched

Effective date: 19990528

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991208